Leptomeningeal metastasis in solid tumours: Is there a role for intrathecal therapy?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kosmas, 2002, Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer, J Neuro Oncol, 56, 265, 10.1023/A:1015018808804
Jayson, 1994, Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant, Cancer, 74, 3135, 10.1002/1097-0142(19941215)74:12<3135::AID-CNCR2820741212>3.0.CO;2-8
Lamovec, 1991, Metastatic pattern of infiltrating lobular carcinoma of the breast. An autopsy study, J Surg Oncol, 48, 28, 10.1002/jso.2930480106
Rosen, 1982, Carcinomatous leptomeningitis in small cell lung cancer. A clinicopathologic review of the National Cancer Institute experience, Medicine, 61, 45, 10.1097/00005792-198201000-00005
Seute, 2005, Leptomeningeal metastases from small cell lung carcinoma, Cancer, 104, 1700, 10.1002/cncr.21322
Olson, 1974, Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study, Arch Neurol, 30, 122, 10.1001/archneur.1974.00490320010002
Amer, 1978, Malignant melanoma and central nervous system metastases, Cancer, 42, 660, 10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E
Nugent, 1979, CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival, Cancer, 44, 1885, 10.1002/1097-0142(197911)44:5<1885::AID-CNCR2820440550>3.0.CO;2-F
Aroney, 1981, Meningeal carcinomatosis in small cell carcinoma of the lung, Am J Med, 71, 26, 10.1016/0002-9343(81)90254-0
Wasserstrom, 1982, Diagnosis and treatment of leptomeningeal metastases from solid tumours. Experience with 90 patients, Cancer, 49, 759, 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7
Tsukada, 1983, Central nervous system metastasis from breast carcinoma. Autopsy study, Cancer, 52, 2349, 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B
Lee, 2003, Leptomeningeal carcinomatosis in gastric cancer, J Neuro Oncol, 66, 167, 10.1023/B:NEON.0000013462.43156.f4
Posner, 1995
Little, 1974, Meningeal carcinomatosis. Clinical manifestations, Arch Neurol, 30, 138, 10.1001/archneur.1974.00490320026003
Ongerboer de Visser, 1983, Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma, Neurology, 33, 1565, 10.1212/WNL.33.12.1565
Gonzalez-Vitale, 1976, Meningeal carcinomatosis, Cancer, 37, 2906, 10.1002/1097-0142(197606)37:6<2906::AID-CNCR2820370648>3.0.CO;2-D
Kokkoris, 1983, Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid?, Cancer, 51, 154, 10.1002/1097-0142(19830101)51:1<154::AID-CNCR2820510130>3.0.CO;2-K
Lee, 2003, Leptomeningeal carcinomatosis in gastric cancer, J Neuro Oncol, 66, 167, 10.1023/B:NEON.0000013462.43156.f4
Norris, 1997, Neoplastic meningitis following surgical resection of isolated cerebellar metastasis. A potentially preventable complication, J Neuro Oncol, 32, 215, 10.1023/A:1005723801479
van der Ree, 1999, Leptomeningeal metastasis after surgical resection of brain metastases, J Neurol Neurosurg Psychiatry, 66, 225, 10.1136/jnnp.66.2.225
Suki, 2006, Risk of leptomeningeal disease after surgery versus radiotherapy for posterior fossa metastases. Perspectives in CNS malignancies, Budapest, 45
Klein, 1989, Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases, Arch Neurol, 46, 1149, 10.1001/archneur.1989.00520460145030
Hiesiger, 1989, Experimental meningeal carcinomatosis selectively depresses local cerebral glucose utilization in rat brain, Neurology, 39, 90, 10.1212/WNL.39.1.90
Balm, 1996, Leptomeningeal carcinomatosis. Presenting features and prognostic factors, Arch Neurol, 53, 626, 10.1001/archneur.1996.00550070064013
Boogerd, 1993, Brain metastases in breast cancer; natural history, prognostic factors and outcome, J Neuro Oncol, 15, 165, 10.1007/BF01053937
Freilich, 1995, Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis, Ann Neurol, 38, 51, 10.1002/ana.410380111
Straathof, 1999, The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis, J Neurol, 246, 810, 10.1007/s004150050459
Collie, 1999, Imaging features of leptomeningeal metastases, Clin Radiol, 54, 765, 10.1016/S0009-9260(99)91181-9
Davis, 1987, Leptomeningeal metastasis. MR imaging, Radiology, 163, 449, 10.1148/radiology.163.2.3562825
Chamberlain, 1990, Leptomeningeal metastasis. A comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain, Neurology, 40, 435, 10.1212/WNL.40.3_Part_1.435
Boogerd, 1991, Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment, Cancer, 67, 1685, 10.1002/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M
Glantz, 1998, Cerebrospinal fluid cytology in patients with cancer. Minimizing false-negative results, Cancer, 82, 733, 10.1002/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z
Kaplan, 1990, Leptomeningeal metastases. Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias, J Neuro Oncol, 9, 225, 10.1007/BF02341153
Rogers, 1992, Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis, Neurology, 42, 1239, 10.1212/WNL.42.6.1239
Boogerd, 1988, CSF cytology versus immunocytochemistry in meningeal carcinomatosis, J Neurol Neurosurg Psychiatry, 51, 142, 10.1136/jnnp.51.1.142
Cibas, 1987, Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid, Am J Clin Pathol, 88, 570, 10.1093/ajcp/88.5.570
Kleinschmidt-DeMasters, 1998, Part II. Telomerase expression in cerebrospinal fluid specimens as an adjunct to cytologic diagnosis, J Neurol Sci, 161, 124, 10.1016/S0022-510X(98)00254-8
Oostenbrugge, 1997, Detection of malignant cells in cerebrospinal fluid using fluorescence in situ hybridization, J Neuropathol Exp Neurol, 56, 743, 10.1097/00005072-199706000-00012
Oostenbrugge, 1998, The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases, Neurology, 51, 906, 10.1212/WNL.51.3.906
Murray, 1983, Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural block, Am J Med, 75, 289, 10.1016/0002-9343(83)91207-X
Oschmann, 1994, Meningeal carcinomatosis. CSF cytology, immunocytochemistry and biochemical tumor markers, Acta Neurol Scand, 89, 395, 10.1111/j.1600-0404.1994.tb02653.x
Chamberlain, 1998, Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers, Neurology, 50, 1173, 10.1212/WNL.50.4.1173
Stockhammer, 2000, Vascular endothelial growth factor in CSF. A biological marker for carcinomatous meningitis, Neurology, 54, 1670, 10.1212/WNL.54.8.1670
Herrlinger, 2004, Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis. Diagnostic and prognostic value, Br J Cancer, 91, 219, 10.1038/sj.bjc.6601953
Gomori, 1998, Leptomeningeal metastases. Evaluation by gadolinium enhanced spinal magnetic resonance imaging, J Neuro Oncol, 36, 55, 10.1023/A:1005783507544
Siegal, 1994, Leptomeningeal metastases. Analysis of 31 patients with sustained off-therapy response following combined-modality therapy, Neurology, 44, 1463, 10.1212/WNL.44.8.1463
Grossman, 1982, Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography, Am J Med, 73, 641, 10.1016/0002-9343(82)90404-1
Glantz, 1995, Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status, Cancer, 75, 2919, 10.1002/1097-0142(19950615)75:12<2919::AID-CNCR2820751220>3.0.CO;2-9
Chamberlain, 1996, Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases, Neurology, 46, 1674, 10.1212/WNL.46.6.1674
Mason, 1998, 111Indium-diethylene- triamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases, Neurology, 50, 438, 10.1212/WNL.50.2.438
Hermann, 2001, Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis, Strahlenther Onkol, 177, 195, 10.1007/PL00002398
Brown, 1996, Intrathecal 131 I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results, Clin Cancer Res, 2, 963
Lashfford, 1988, A pilot study of 1311 monoclonal antibodies in the therapy of leptomeningeal tumors, Cancer, 61, 857, 10.1002/1097-0142(19880301)61:5<857::AID-CNCR2820610502>3.0.CO;2-S
Boogerd, 1988, Acute fever and delayed leuko-encephalopathy following low dose intraventricular methotrexate, J Neurol neurosurg Psychiatry, 51, 1277, 10.1136/jnnp.51.10.1277
Grossman, 1993, Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group, J Clin Oncol, 11, 561, 10.1200/JCO.1993.11.3.561
Hitchins, 1987, A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis, J Clin Oncol, 5, 1655, 10.1200/JCO.1987.5.10.1655
Giannone, 1986, Combination intraventricular chemotherapy for meningeal neoplasia, J Clin Oncol, 4, 68, 10.1200/JCO.1986.4.1.68
Glantz, 1999, A randomized controlled trial comparing intrathecal sustained- release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors, Clin Cancer Res, 5, 3394
Chamberlain, 2002, A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis, Cancer, 94, 2675, 10.1002/cncr.10547
Nakagawa, 1999, Clinical trial of intrathecal administration of 5-fluoro-2′-deoxyuridine for treatment of meningeal dissemination of malignant tumors, J Neuro-Oncol, 45, 175, 10.1023/A:1006373905428
Chamberlain, 2006, Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis, Cancer, 106, 2021, 10.1002/cncr.21828
Blaney, 1992, A phase I study of intrathecal mafosfamide (MF) in patients with refractory meningeal malignancies. (Absract 274), Porc Am Soc Clin Oncol, 11, 113
Platini, 2006, Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab, Lancet Oncol, 7, 888
Shapiro, 1975, Methotrexate. Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections, N Engl J Med, 293, 161, 10.1056/NEJM197507242930402
Kim, 1993, Extended CSF cytarabine exposure following intrathecal administration of DTC 101, J Clin Oncol, 11, 2186, 10.1200/JCO.1993.11.11.2186
Yap, 1982, Treatment for meningeal carcinomatosis in breast cancer, Cancer, 50, 219, 10.1002/1097-0142(19820715)50:2<219::AID-CNCR2820500209>3.0.CO;2-7
Shapiro, 1977, Treatment of meningeal neoplasms, Cancer Treat Rep, 61, 733
Esteva, 2000, Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer, Cancer Chemother Pharmacol, 46, 382, 10.1007/s002800000173
Bokstein, 1998, Leptomeningeal metastases from solid tumors, a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy, Cancer, 82, 1756, 10.1002/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1
Grant, 1994, Clinical outcome in aggressively treated meningeal carcinomatosis, Arch Neurol, 51, 457, 10.1001/archneur.1994.00540170033013
Jaeckle, 2001, Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine, Br J Cancer, 84, 157, 10.1054/bjoc.2000.1574
Stewart, 1987, Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thio-TEPA for meningeal involvement by malignancies, J Neuro Oncol, 5, 315, 10.1007/BF00148388
Orlando, 2002, Intrathecal chemotherapy in carcinomatous meningitis from breast cancer, Anticancer Res, 22, 3057
Jaeckle, 2002, An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis, J Neuro Oncol, 57, 231, 10.1023/A:1015752331041
Chamberlain, 2004, Neoplastic meningitis related encephalopathy. Prognostic significance, Neurology, 63, 2159, 10.1212/01.WNL.0000145599.06491.71
Herrlinger, 2004, Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis. Diagnostic and prognostic value, Br J Cancer, 91, 219, 10.1038/sj.bjc.6601953
Chamberlain, 1997, Prognostic significance of coexistent bulky metastatic central nervous system disease in patiënts with leptomeningeal metastases, Arch Neurol, 54, 1354, 10.1001/archneur.1997.00550230037013
Siegal, 1998, Leptomeningeal metastases. Rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?, J Neuro Oncol, 38, 151, 10.1023/A:1005999228846
Boogerd, 2004, The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer. A randomised study, Eur J Cancer, 40, 2726, 10.1016/j.ejca.2004.08.012
Lishner, 1990, Complications associated with Ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature, Arch Intern Med, 150, 173, 10.1001/archinte.150.1.173
Chamberlain, 1997, Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases, J Neurosurg, 87, 694, 10.3171/jns.1997.87.5.0694
Obbens, 1985, Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies, J Neuro Oncol, 3, 61, 10.1007/BF00165173
Trump, 1982, Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate, Cancer Treat Rep, 66, 1549
Lemann, 1988, Leuko-encephalopathy complicating intraventricular catheters: clinical, radiographic and pathologic study of 10 cases, J Neuro Oncol, 6, 67, 10.1007/BF00163543
Boogerd, 1990, Early blindness and coma during intrathecal chemotherapy for meningeal coarcinomatosis, Cancer, 65, 452, 10.1002/1097-0142(19900201)65:3<452::AID-CNCR2820650313>3.0.CO;2-8
Bokstein, 1998, Leptomeningeal metastases from solid tumours: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy, Cancer, 82, 1756, 10.1002/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1
Bleyer, 1981, Neurologic sequelae of methotrexate and ionizing radiation: A new classification, Cancer Treat Rep, 65, 89
Cole, 2003, Quality-of-life-adjusted survival comparison of sustained- release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis, Cancer, 97, 3053, 10.1002/cncr.11449
Watterson, 1994, Excessive spinal cord toxicity from intensive central nervous system-directed therapies, Cancer, 74, 3034, 10.1002/1097-0142(19941201)74:11<3034::AID-CNCR2820741122>3.0.CO;2-O
Ushio, 1981, Alteration of blood-CSF barrier by tumor invasion into the meninges, J Neurosurg, 55, 445, 10.3171/jns.1981.55.3.0445
Glantz, 1998, High-dose intravenous methotrexate for patiënts with nonleukemic leptomeningeal cancer. Is intrathecal chemotherapy necessary?, J Clin Oncol, 16, 1561, 10.1200/JCO.1998.16.4.1561
Tetef, 2000, Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis, Cancer Chemother Pharmacol, 46, 19, 10.1007/s002800000118
Giglio, 2003, Response of neoplastic meningitis from tumors to oral capecitabine, J Neuro Oncol, 65, 167, 10.1023/B:NEON.0000003752.89814.ca
Boogerd, 2000, Response of leptomeningeal metastases from breast cancer to hormonal therapy, Neurology, 55, 117, 10.1212/WNL.55.1.117
Rogers, 2004, Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy, Neuro-oncol, 6, 63, 10.1215/S1152851703000334